Sunday 18 October 2026 Export VNDA’s income statement to Excel — free account

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $216.1 million, up 8.72% from fiscal 2024. In the quarter to June 2026, revenue fell 3.92%, EPS fell 126.1%, free cash flow fell 101.0% and total debt rose 2.98%, each against the same quarter a year earlier.

4.03 0.21 −4.95%

Follow VNDA

Alert me

Market cap: $256.4M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 2/9
Altman Z: 0.72
Beneish M: −3.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	2	2	2
ROE Full definition →		(16.72%)	(50.93%)	(60.48%)	(77.81%)
ROA Full definition →		(13.51%)	(38.51%)	(44.97%)	(53.00%)
ROIC Full definition →		(43.23%)	(140.15%)	(121.87%)	(217.59%)
Return on Tangible Assets Full definition →		(33.40%)	(107.89%)	(149.87%)	(266.75%)
Average Days of Receivables Full definition →		86.99	92.18	95.33	101.00
Free Cash Flow per Share Full definition →		(1.40)	(1.87)	(2.31)	(2.54)
Free Cash Flow Full definition →		(82.95)	(110.44)	(137.30)	(153.00)
Capital Expenditures Full definition →		(1.11)	(1.00)	(10.78)	(10.67)
Other line items
Cash ROIC Full definition →		(10.88%)	(18.56%)	(28.20%)	(38.89%)
Accounts Receivable Turnover Full definition →		4.55	4.25	4.29	4.12
Accounts Payable Turnover Full definition →		0.27	0.24	0.24	0.21
Inventory Turnover Full definition →		6.46	7.29	7.00	7.02
Average Days of Payables Full definition →		1,472.84	1,911.10	1,744.70	1,891.59
Days of Inventory on Hand Full definition →		63.16	51.82	48.90	45.35
Tax Rate Full definition →		(0.21)	0.59	0.60	0.55
Research and Development Expense of Revenue Full definition →		47.20%	50.56%	46.83%	54.22%
Selling, General and Administrative Expense of Revenue Full definition →		101.03%	110.11%	117.65%	122.13%
Share Based Compensation of Revenue Full definition →		4.74%	4.38%	4.16%	4.20%
Operating CF/Net income Full definition →		0.97	0.50	0.53	0.52
Depreciation/Fixed assets Full definition →		2.59	4.39	4.98	4.85
Capex/Depreciation Full definition →		(0.17)	(0.10)	(0.96)	(0.85)
Revenue per Share Full definition →		3.59	3.67	3.66	3.58
Operating CF per Share Full definition →		(1.38)	(1.86)	(2.13)	(2.36)
Capex per Share Full definition →		(0.02)	(0.02)	(0.18)	(0.18)
Capex to Sales Full definition →		0.01	0.00	0.05	0.05

Show all line items

Columns are period end dates

Stockrow Weekly